NCT03979157

Brief Summary

This study aims to determine hemoglobin and collagen levels in muscles before and after exercise, and over time, using Multispectral Optoacoustic Tomography (MSOT). During MSOT, a transducer is placed on the skin similar to a conventional sonography and instead of sound, energy is supplied to the tissue by means of light flashes. This leads to a constant change of minimal expansions and contractions (thermoelastic expansion) of individual tissue constituents or molecules. The resulting sound waves can then be detected by the same examination unit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 7, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

October 14, 2019

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2019

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2020

Completed
Last Updated

July 7, 2020

Status Verified

July 1, 2020

Enrollment Period

28 days

First QC Date

June 3, 2019

Last Update Submit

July 1, 2020

Conditions

Keywords

Muscular DiseasesDuchenne muscular diseaseMSOT

Outcome Measures

Primary Outcomes (2)

  • Muscular collagen content

    Quantitative collagen signal derived by transcutaneous Multispectral Optoacoustic Tomography (MSOT) in muscles of healthy volunteers compared before and after 6-MWT.

    one time point ( 2 measurements on day 1)

  • Muscular myo-/hemoglobin content

    Quantitative myo-/hemoglobin signal derived by transcutaneous Multispectral Optoacoustic Tomography (MSOT) in muscles of healthy volunteers compared before and after 6-MWT.

    one time point ( 2 measurements on day 1)

Secondary Outcomes (18)

  • Muscular oxygenated and deoxygenated myo-/hemoglobin content

    multiple time points ( 2 measurements on day 1 and 2 measurements on day 15)

  • Intraindividual collagen content

    multiple time points ( 2 measurements on day 1 and 2 measurements on day 15)

  • Intraindividual myo-/hemoglobin content

    multiple time points ( 2 measurements on day 1 and 2 measurements on day 15)

  • Intraindividual oxygenated and deoxygenated myo-/hemoglobin content

    multiple time points ( 2 measurements on day 1 and 2 measurements on day 15)

  • Muscular collagen content in men and women

    multiple time points ( 2 measurements on day 1 and 2 measurements on day 15)

  • +13 more secondary outcomes

Study Arms (1)

Healthy Volunteers

EXPERIMENTAL

Multispectral Optoacoustic Tomography (MSOT) of proximal and distal leg muscles (total of 12 sites: left and right, 3 measurement points of Musculus quadriceps, and 3 measurement points of Musculus triceps surae) before and after the 6-Minute-Walk-Test by to independent investigators. Repetition of the same protocol after 14 days.

Device: Multispectral Optoacoustic Tomography

Interventions

Non-invasive transcutaneous imaging of subcellular muscle components

Healthy Volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>18 years of age

You may not qualify if:

  • any reference to a myopathy
  • pregnancy
  • tattoo in the scanning region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Erlangen

Erlangen, Bavaria, 91054, Germany

Location

MeSH Terms

Conditions

Muscular Diseases

Condition Hierarchy (Ancestors)

Musculoskeletal DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Adrian Regensburger, Dr.

    Department of Pediatrics and Adolescent Medicine, University of Erlangen

    PRINCIPAL INVESTIGATOR
  • Ferdinand Knieling, Dr.

    Department of Pediatrics and Adolescent Medicine, University of Erlangen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2019

First Posted

June 7, 2019

Study Start

October 14, 2019

Primary Completion

November 11, 2019

Study Completion

June 23, 2020

Last Updated

July 7, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will share

The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request as follows: * Individual participant data will not be available * Study Protocol and Statistical Analysis Plan will be available * The data will be available beginning 9 months and ending 36 months following article publication. * The data will be available to researchers who provide a methodologically sound proposal. * The data will be available for individual participant data for meta-analysis, only. * Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Information regarding submitting proposals and accessing data may be found at https://www.uk-erlangen.de. Restrictions may apply due to patient privacy and the General Data Protection Regulation.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
36 months after publication
Access Criteria
Resonable request

Locations